Advertisement
U.S. markets open in 8 hours 48 minutes

Aquestive Therapeutics, Inc. (AQST)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
4.8800+0.0700 (+1.46%)
At close: 04:00PM EST
4.8500 -0.03 (-0.61%)
After hours: 07:53PM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
58,900
50,583
47,680
50,832
45,849
Cost of Revenue
18,031
20,831
19,386
14,989
12,964
Gross Profit
40,869
29,752
28,294
35,843
32,885
Operating Expense
61,972
44,854
70,360
70,522
75,778
Operating Income
-21,103
-15,102
-42,066
-34,679
-42,893
Net Non Operating Interest Income Expense
-12,960
8,859
-12,344
-22,038
-12,890
Other Income Expense
-
-1,382
-
-13,822
-
Pretax Income
-35,092
-7,625
-54,410
-70,539
-55,783
Tax Provision
101
245
0
0
0
Net Income Common Stockholders
-35,193
-7,870
-54,410
-70,539
-55,783
Diluted NI Available to Com Stockholders
-35,193
-7,870
-54,410
-70,539
-55,783
Basic EPS
-0.22
-0.13
-1.12
-1.85
-1.66
Diluted EPS
-0.22
-0.13
-1.12
-1.85
-1.66
Basic Average Shares
58,053
61,256
48,734
38,078
33,651
Diluted Average Shares
59,749
61,256
48,734
38,078
33,651
Total Operating Income as Reported
-21,103
-15,102
-42,066
-34,679
-42,893
Total Expenses
80,003
65,685
89,746
85,511
88,742
Net Income from Continuing & Discontinued Operation
-35,193
-7,870
-54,410
-70,539
-55,783
Normalized Income
-34,380
-6,533
-54,410
-56,734
-55,783
Interest Income
2,868
16,321
99
423
132
Interest Expense
15,828
7,462
12,443
22,461
13,022
Net Interest Income
-12,960
8,859
-12,344
-22,038
-12,890
EBIT
-19,264
-163
-41,967
-48,078
-42,761
EBITDA
-18,225
1,182
-39,580
-45,114
-39,318
Reconciled Cost of Revenue
18,031
20,831
19,386
14,989
12,964
Reconciled Depreciation
1,039
1,345
2,387
2,964
3,443
Net Income from Continuing Operation Net Minority Interest
-35,193
-7,870
-54,410
-70,539
-55,783
Total Unusual Items Excluding Goodwill
-1,029
-1,382
0
-13,822
0
Total Unusual Items
-1,029
-1,382
0
-13,822
0
Normalized EBITDA
-17,196
2,564
-39,580
-31,292
-39,318
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-216.09
-44.5004
0
-16.5864
0